Endophytic fungi: A future prospect for breast cancer therapeutics and drug development

Sherin Varghese1, M S Jisha1, K C Rajeshkumar2

  • 1School of Biosciences, Mahatma Gandhi University, Kottayam, Kerala, 686560, India.

Heliyon
|August 2, 2024
PubMed

Insights

Endophytic fungi from medicinal plants offer a promising source for novel breast cancer treatments. This review highlights their bioactive compounds and potential for developing new anticancer drugs.

Area of Science:

  • Pharmacology
  • Mycology
  • Oncology

Background:

  • Breast cancer remains a leading cause of cancer-related deaths in women globally, necessitating novel therapeutic strategies.
  • Endophytic fungi, symbiotic microorganisms residing within medicinal plants, produce diverse bioactive compounds with significant pharmaceutical potential.
  • These fungal endophytes are increasingly recognized as a valuable resource for discovering new anticancer agents.

Purpose of the Study:

  • To review the potential of endophytic fungi as a source for developing innovative anticancer agents for breast cancer therapy.
  • To compile and analyze bioactive metabolites from endophytic fungi with demonstrated therapeutic potential against breast cancer from 1990 to 2022.
  • To discuss current trends, challenges, and future prospects in endophyte-based drug discovery for breast cancer.

Main Methods:

  • Comprehensive literature review of scientific databases (e.g., PubMed, Scopus) from 1990 to 2022.
  • Identification and compilation of endophytic fungi and their bioactive metabolites with reported anticancer activity against breast cancer.
  • Analysis of current research trends, including artificial intelligence, machine learning, and multi-omics approaches in endophyte-based drug discovery.

Main Results:

  • A wide array of endophytic fungi from medicinal plants harbor bioactive compounds with potent anticancer activities against breast cancer cell lines.
  • Several key endophytic metabolites have shown promising results in preclinical (in vivo) studies and are progressing towards clinical trials.
  • The review details specific compounds, their sources, mechanisms of action, and efficacy against various breast cancer models.

Conclusions:

  • Endophytic fungi represent a rich and underexplored reservoir for the discovery of novel, effective, and potentially safer anticancer drugs for breast cancer treatment.
  • Integration of advanced technologies like AI and multi-omics can accelerate the identification and development of these fungal-derived therapeutics.
  • Further research and clinical investigations are crucial to fully harness the therapeutic potential of endophytic fungi in combating breast cancer.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K